◇ Gilead, Senior Vice President Joo-yeon Lee and Legal Director Won-joon Cho appointed
Gilead Science Korea (CEO Seung-woo Lee) announced that it has newly appointed Managing Director Joo-yeon Lee as the head of the medical department and Won-joon Cho as the head of the legal department.
The greetings were made as Vice President Choi Hyun-ah and Vice President Han Man-hee of Gilead Science Korea took over as general manager of Asia 5 (Korea, Taiwan, Hong Kong, Singapore, Malaysia) of Gilead Science.
Lee Joo-yeon started as a medical advisor at Sanofigenzyme and Sanofiaventis, served as the Head of Medical at Sanofiaventis General Medicine and Established Products, and has served as the general manager of Biogen Korea Medical since 2017.
Meanwhile, he will lead the medical department of Gilead Science Korea based on his expertise recognized in various fields such as neurological diseases, rare diseases, chronic kidney diseases, and cardiovascular diseases.
Director Lee graduated from Yeungnam University College of Medicine and completed a residency course in the Department of Anesthesiology and Pain Medicine at Seoul Samsung Hospital.
Cho Won-joon, who was appointed as the General Manager of Legal Affairs and Compliance, is a lawyer in New York State, USA. For 15 years, he has performed various duties at major domestic law firms such as Sejong Law Firm and Jipyeong Law Firm, leading companies and multinational corporations. He has served as Head of Compliance.
Senior Vice President Cho graduated from University of California, Davis, USA, and received a Juris Doctor from New Hampshire University, and managed the Sungkyunkwan University-Kelley School of Business. He is in the vocational graduate school’s MBA course.
Seung-Woo Lee, CEO of Gilead Science Korea, said, “This greeting is due to the fact that Hyun-ah Choi, vice president of Gilead Science Korea, who oversees the innovative product portfolio of Gilead Science Korea and related medical affairs, and Man-hee Han, who was responsible for legal affairs and compliance, became the head of Asia 5. As a result, we are pleased to have newly joined medical and healthcare legal experts Lee Ju-yeon and Cho Won-joon. “With the two newly joined experts, we are committed to the development and supply of innovative therapeutics in various fields where medical needs are not met. We will do our best to improve the treatment environment for various disease groups.”
◇Boehringer Ingelheim, selected as’Best Employment Company of 2021′ in 6 Asian countries other than Korea
Boehringer Ingelheim was awarded the Best Employer in 2021 in 6 countries outside Korea (Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam) from Top Employer Institute, a global organization that evaluates the excellence of corporate talent policy. Top Employer). Boehringer Ingelheim has been certified as the best employer for the second year in a row, not only in Korea, but also in Asia as a whole.
In addition, Boehringer Ingelheim was selected as the first Global Top Employer, not only in the local market and in Asia.
Only 16 companies in the world were selected as the best global employers by the Employment Excellence Association this year.
Boehringer Ingelheim has been recognized as an active and holistic HR approach that aims for a culture of inclusion and growth based on a dynamic talent pool consisting of 2,000 people from 24 countries in the Asia-Pacific region.
Boehringer Ingelheim provides employee information, including implementing salary and employment protection measures for employees affected by COVID-19, supporting smooth transition to work from home, and implementing various support measures for the mental and physical health and emotional well-being of employees. In order to strengthen participation and communication, several COVID-19 response initiatives have been introduced.
In particular, Boehringer Ingelheim Korea, among the COVID-19 pandemic, provides sanitation kits consisting of a reinforced flexible working system, monthly masks and hand sanitizers to promote employee safety and work-life balance. Efforts were made to provide a safe working environment by regularly guiding the company’s quarantine regulations according to the two rules.
In addition, to emphasize the importance of respecting diversity, we conducted a’Diversity & Inclusion’ campaign, and strived to strengthen employee engagement and bonds by utilizing a forum for communication with all employees, while also strengthening effective telecommuting and managerial capabilities. It has provided a variety of education for students.
Boehringer Ingelheim Southeast Asia and Korea Regional President Armin Wiesler said, “It is an honor to be recognized once again by the Outstanding Employment Association for its people-centered management across the Asia Pacific region among the COVID-19 pandemic.” “It demonstrates a strong corporate culture that prioritizes the well-being, safety and growth of employees.”
Furthermore, he said, “Boehringer Ingelheim will spare no effort to support its employees so that they can continue to have a positive impact on the community by improving the quality of life of humans and animals in an era of uncertainty such as the COVID-19 pandemic.”
Regarding this selection, David Serés, General Manager of the Department of Human Resources for Southeast Asia and Korea in Boehringer Ingelheim, said, “Boehringer Ingelheim has diversity, dynamism and agility that can quickly adapt to changing human and animal healthcare needs. I am proud to have fostered a talent pool.”
“Even in a difficult environment due to the COVID-19 pandemic, all employees are making ceaseless efforts to meet the needs of patients in the face of the crisis.” “The certification of the Excellent Employment Association has been and will continue to be strengthened by Boehringer Ingelheim. By demonstrating the outstanding employee hiring experience we want to do, Boehringer Ingelheim wants to empower our employees to reach their full potential.”
Stephen Walter, President of Boehringer Ingelheim Korea, said, “I am very pleased to be selected as the best employment company once again.” We plan to provide generous support to actively embrace the existing digitalization.”
In addition, he said, “We will do our best to create a good workplace suitable for the changing work environment and corporate culture due to the COVID-19 pandemic.”
On the other hand, this certification program operated by the Excellent Employment Association is awarded based on participation in the HR Best Practices Survey and the results of the survey.
The survey consists of 20 topics in the six HR sectors: talent strategy, work environment, talent acquisition, learning, well-being, diversity and inclusion. The Outstanding Employment Association has certified and selected over 1,600 companies in 120 countries on 5 continents.
◇Korea Ferring Pharmaceutical delivered a donation to Cambodian drinking water support project for night urine disease awareness campaign
Ferring Pharmaceutical Korea (CEO Yong-beom Choi) conducted a nocturia disease awareness campaign to minimize evening water intake for patients with nocturia, and delivered the donations collected through this to the international aid and development NGO World Share (Chairman Park Hyun-mo)’s drinking water support project in Cambodia Sun said
Under the theme of the slogan’Why not minimize drinking water in the evening?’, this campaign conveys a message that it is possible to induce a healthy sleep of nocturia patients by limiting drinking water in the evening. At the same time, it was designed to sympathize with the thirst of children in water-shortage countries suffering from lack of drinking water and to help them.
The campaign, which has been held for about a month since the end of November last year, was successfully carried out by not only employees of Ferring Pharmaceutical Korea, but also urologists from all over the country.
The medical staff participated in the thirst of children in countries with water shortages by playing a simple mini-game prepared on the web page, and the employees of Ferring Pharmaceutical Korea also created a magic wall that symbolizes the creation of a well with a glass of water reduced in the evening. ) Was installed in-house to conduct internal events and recall the meaning of the campaign.
CEO Choi Yong-beom of Ferring Pharmaceutical Korea said, “We are pleased that the campaign was successfully ended with the participation of many medical staff in the hope that patients who are treating night urine can receive more safe treatment by limiting water intake in the evening.” Pharmaceuticals will continue to actively support those in need through various social contribution activities as well as the development of innovative treatments.”
On the other hand, nocturia is a disease that wakes up more than once to urinate during sleep, and can cause sleep disorders, chronic fatigue, and depression, which greatly affects the quality of life.
It is helpful to limit fluid intake in the evening as symptomatic therapy, and desmopressin preparations especially for nocturia patients who have a lot of urine at night help improve symptoms of nocturia.
Copyright © Medical News Unauthorized reproduction and redistribution prohibited